防熒光淬滅封片劑
UltraCruz ® Mounting Medium(cat# sc-24941)
背景簡介：
UltraCruz ®封片劑是一種水溶性封片劑。該封片劑可有效抵抗種熒光，包括FTIC, Texas Red，Rhodamined等熒光淬滅。
產(chǎn)品描述：
UltraCruz ®封片劑 為含DAPI（1.5ug/ml） 封片劑，用于原位雜交以及其他DNA熒光標(biāo)記系統(tǒng)實驗的封片劑。含DAPI 封片劑也可于RNA染色。
產(chǎn)品應(yīng)用：
- 對于要封片的組織或細(xì)胞切片，滴一滴封片劑到載玻片上。
- 蓋上蓋玻片，讓封片劑分散覆蓋到整個區(qū)域（不建議用過量的封片劑封片）。
- UltraCruz ®封片劑不會固化，仍是在切片上呈液體形式。封片后的載玻片不會立即干燥，如果不封邊可以復(fù)查數(shù)周。
- 為了延長切片保存時間，可以用指甲油或塑料密封劑繞蓋玻片四周封邊。封邊后的玻片4℃避光保存。
產(chǎn)品保存：
4℃避光保存，效期1年。
應(yīng)用實例：
產(chǎn)品訂購：
| 品牌 |
貨號 |
產(chǎn)品名稱 |
規(guī)格 |
| Santa Cruz |
cat# sc-24941 |
UltraCruz ® Mounting Medium |
10ml |
產(chǎn)品引用文獻(xiàn)：
1. Dey, S., et al. 2009. Cell cycle specific expression and nucleolar localization of human J-domain containing co-chaperone Mrj. Mol. Cell. Biochem. 322: 137-142.
2. Muralidhar, S.A., et al. 2011. Histone deacetylase 9 activates g-globin gene expression in primary erythroid cells. J. Biol. Chem. 286: 2343-2353.
3. Shao, C., et al. 2014. Activation of angiotensin type 2 receptors partially ameliorates streptozotocin-induced diabetes in male rats by islet protection. Endocrinology 155: 793-804.
4. Kanno, S., et al. 2015. Pifithrin-a has a p53-independent cytoprotective effect on docosahexaenoic acid-induced cytotoxicity in human hepatocellular carcinoma HepG2 cells. Toxicology letters. 232: 393-402.
5. Ito, T., et al. 2016. Activation of the OVOL1-OVOL2 axis in the hair bulb and in pilomatricoma. Am. J. Pathol. 186: 1036-1043.
6. Sterzynska, K., et al. 2018. Myotilin, a new topotecan resistant protein in ovarian cancer cell lines. J. Cancer 9: 4413-4421.
7. Gkouveris, I., et al. 2019. Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ). Bone 123: 234-245.
8. Shimokawa, M., et al. 2020. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma. Cancer Sci. 111: 1228-1240.
9. Leerach, N., et al. 2021. RAGE signaling antagonist suppresses mouse macrophage foam cell formation. Biochem. Biophys. Res. Commun. 555:74-80.
